Finding hidden atrial fibrillation in mitral valve disease
Part of Heart & circulation clinical trials.
This study looks for hidden (subclinical) atrial fibrillation in people with significant primary mitral regurgitation who have no symptoms or only mild symptoms. Researchers want to see if this heart-rhythm issue occurs without being noticed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have significant mitral regurgitation (a leaky heart valve) but no or only mild symptoms.
- Your heart's pumping strength (LVEF) is 60% or more – meaning it's still strong.
- You have your own (native) mitral valve, not a replaced or repaired one.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment for people with atrial fibrillation who also have a leaky mitral valve. It aims to see if treating both conditions together can improve symptoms.
This study tests whether a catheter ablation procedure (a way to fix abnormal heart rhythms) can help people who have both constant atrial fibrillation and severe mitral regurgitation (a leaky heart valve). It is for people whose heart valve leak is caused by the rhythm problem, not by valve damage.
This study tests whether catheter ablation (a procedure to correct irregular heartbeats) helps people with atrial fibrillation who have already had a successful MitraClip repair for a leaky mitral valve. It aims to see if the ablation improves heart rhythm and quality of life.
This study is for people with atrial fibrillation who are planning to have a catheter ablation procedure. It will look at how well the heart works after the procedure and how to prevent future events.
This trial tests a procedure that combines two treatments for people with atrial fibrillation and a leaky mitral valve that causes symptoms. The procedure aims to fix the valve leak and restore normal heart rhythm, which may improve quality of life and reduce symptoms.
This study uses advanced heart scans and AI technology to find early signs of amyloidosis (a protein buildup in the heart) in people with atrial fibrillation. Catching it early may help prevent serious heart problems.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.